Professor of Medicine, Director, ASH Comprehensive Hypertension Center
Nephrology
George Bakris is an expert in the field of Nephrology. He has 23 awards "Chicago Magazine: Top Doctors", "America's Top Doctors", "Castle Connolly Top Doctors", "Astra Zeneca Award", "Listed Referenced No. 1 in Hypertension", "Listed Referenced No.2 in Diabetic Nephropathy", "CMS Meaningful Use Stage 1 Certification", "Top Doctors", "Listed ", "Honorary Doctorate Degree", "Listed-America's Top Doctors", "American Diabetes Association", "Distinguished Physician Award", "Father of the Year Award", "National Award- Comprehensive Excellence in Med Ed.", "South Texas Award", "National Award- Comprehensive Excellence in Med Education", "National Kidney Foundation of South Texas Award", "Comprehensive Excellence in Medical Education", "Scholastic Award", "Chicago Medical School Scholastic Award", "Whos Who in Medicine and Healthcare" and "Fellow (ASNF)". Dr. George Bakris is a published doctor as well. He has 58 publications published. The latest was: Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial. He accepts Medicare.
Publications
- Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
- Hypertension: SGLT2 inhibitors: not just another glucose-lowering agent.
- From epidemiological transition to modern cardiovascular epidemiology: Hypertension in the 21st century.
- Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit.
- Correlations of plasma renin activity and aldosterone concentration With ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in h...
- The double challenge of resistant hypertension and chronic Kidney disease.
- Effects of aliskiren in diabetic and non-diabetic patients with coronary artery Disease: Insights from AQUARIUS.
- Blood pressure reduction: an added benefit of sodium-glucose cotransporter 2 inhibitors in patients with type 2 Diabetes.
- Heart Failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
- Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart Failure.
- Efficacy and safety of perindopril arginine + amlodipine in Hypertension.
- Hypertension and new treatment approaches targeting the sympathetic nervous system.
- The future of Renal denervation in resistant hypertension.
- Cardiovascular Disease in CKD in 2014: New insights into cardiovascular risk factors and outcomes.
- Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
- Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors.
- Risk Factors for Heart Failure in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl.
- In search for the 'sweet spot' for blood pressure level in Diabetes.
- Renal denervation and left ventricular mass regression: a benefit beyond blood pressure reduction?
- A controlled trial of Renal denervation for resistant hypertension.
- The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension.
- Sorafenib Dose Escalation is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies.
- Metformin nephrotoxicity insights: Will they change clinical management? (：？).
- Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors.
- Evidence-Based Triple Antihypertensive Therapy Yields Lower Mortality in Older Patients With Diabetes Mellitus.
- Early patterns of blood pressure change and future coronary atherosclerosis.
- Review of blood pressure control rates and outcomes.
- Effects of combining azilsartan medoxomil With amlodipine in patients With stage 2 hypertension.
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients with Heart Failure Receiving the Mineralocorticoid Recept...
- Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of ...
- Association of cognitive dysfunction with cardiovascular Disease events in elderly hypertensive patients.
- Bardoxolone methyl in type 2 diabetes and stage 4 chronic Kidney disease.
- Clinical Practice Guidelines for the Management of Hypertension in the Community. A Statement by the American Society of Hypertension and the International Society of ...
- Chronic Kidney disease: Optimal blood pressure for Kidney disease-lower is not better.
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes.
- Determinants and Changes Associated with Aldosterone Breakthrough after Angiotensin II Receptor Blockade in Patients with Type 2 Diabetes with Overt Nephropathy.
- Initial single-pill combination therapy for cardiovascular risk factor management: it is not just convenience.
- KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.
- Interventional cardiology: Indications for Renal denervation: a balanced approach?
- The Future of Interventional Management of Hypertension: threats and opportunities.
- Lowering blood pressure limits in patients with type 2 Diabetes: Is it still warranted?
- Role of Ambulatory Blood Pressure Monitoring in Hypertension and Diabetes.
- Comparison of Benazepril Plus Amlodipine or Hydrochlorothiazide in High-Risk Patients With Hypertension and Coronary Artery Disease.
- Recognition and management of masked Hypertension: A review and novel approach.
- Chronic Kidney disease as a coronary artery disease risk equivalent.
- Clinical guidelines: Blood pressure goals in T2DM: a Latin American perspective.
- Association of BP Variability With Mortality among African Americans With CKD.
- A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic Kidney disease.
- Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
- The OSCAR for cardiovascular disease prevention in chronic Kidney disease goes to blood pressure control.
- Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined With azilsartan medoxomil.
- Hypertension in early-stage Kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
- Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
- Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and Renal outcomes in nephropathy?
- Detection, evaluation, and treatment of severe and resistant Hypertension: Proceedings from an American Society of Hypertension Interactive Forum held in Bethesda, MD,...
- Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 Diabetes mellitu...
Schools
Rosalind Franklin University Of Medicine ScienceThe Chicago Medical School
Mayo Grad School Med
University Of Illinois
University of Chicago
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
Accepted Insurances
Awards
- Chicago Magazine: Top Doctors
- America's Top Doctors
- Castle Connolly Top Doctors
- Astra Zeneca Award
- Listed Referenced No. 1 in Hypertension
- Listed Referenced No.2 in Diabetic Nephropathy
- CMS Meaningful Use Stage 1 Certification
- Top Doctors
- Listed
- Honorary Doctorate Degree
- Listed-America's Top Doctors
- American Diabetes Association
- Distinguished Physician Award
- Father of the Year Award
- National Award- Comprehensive Excellence in Med Ed.
- South Texas Award
- National Award- Comprehensive Excellence in Med Education
- National Kidney Foundation of South Texas Award
- Comprehensive Excellence in Medical Education
- Scholastic Award
- Chicago Medical School Scholastic Award
- Whos Who in Medicine and Healthcare
- Fellow (ASNF)
Education
-
University of Chicago
-
University of Illinois at Chicago
-
Mayo School of Graduate Medical Education
-
Rosalind Franklin University of Medicine and Science
-
Indiana University
Hospital
-
University of Chicago Medical Center
Drug Facts
| NPI NUMBER |
|
1821021619 |
| NPPES Provider LastName |
|
BAKRIS |
| NPPES Provider FirstName |
|
GEORGE |
| NPPES Provider ZIPCode |
|
605277594 |
| NPPES Provider State |
|
IL |
| Specialty Description |
|
Endocrinology |
| Total Claim Count |
|
942.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1821021619 |
| Last Name Of The Provider |
BAKRIS |
| First Name Of The Provider |
GEORGE |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
This doctor has more publications